Earlier this month, a well-known drug manufacturer received word that a CBD-based medication will no longer be regulated under the United States Controlled Substances Act. Epidiolex, a medication made with CBD that is used to treat certain types of epilepsy, will now be marketed as a normal medication. While this is fantastic news, it’s also … Continue reading The DEA Removes CBD From the Controlled Substances Act – But There’s A Catch